Kenya Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Kenya Pharmaceuticals and Healthcare Report Q4 2013 Aug 7th 2013, 00:00, by rnrmahesh BMI View: The Kenyan government is focused on improving its population’s access to healthcare. However, inefficiencies such as the lack of suitable infrastructure and delayed completion of health facility upgrades, the lack of human resources such as nurses and doctors and a slower-than-anticipated uptake of national health insurance programmes could inhibit spending on healthcare and the success of initiatives like the waiving of maternity fees (as of June 1 2013). Headline Expenditure Projections ? Pharmaceuticals: KES47.56bn (US$563mn) in 2012 to KES56.52bn (US$653mn) in 2013; 18.8% growth in local currency terms and 16.0% in US dollar terms. ? Healthcare: KES154.77bn (US$1.83bn) … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=110347. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/kenya-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions